Engrail Therapeutics

Engrail Therapeutics

CA - San Diego
Biotechnology

Focus: Treatments for Life-Limiting Diseases

Engrail Therapeutics is a life sciences company focused on Treatments for Life-Limiting Diseases.

Neurology
Funding Stage
PUBLIC
Open Jobs
0

Pipeline & Clinical Trials

Phase 1
Clinical Trials (1)
NCT07253272A PET Study of ENX-104 in Healthy Volunteers
Phase 1
Clinical Trials (1)
NCT07253324ENX-104 MAD Study for Participants With Major Depressive Disorder With Anhedonia (aMDD)
Phase 1
Phase 1
Clinical Trials (1)
NCT07253246ENX-205 SAD/PET Study in Healthy Adults
Phase 1
Clinical Trials (1)
NCT05749055ENCALM: A Study of ENX-102 as a Monotherapy Treatment in Patients With Generalized Anxiety Disorder
Phase 2
Clinical Trials (1)
NCT06653296A Dose-Response Safety Study of ENX-102 in Patients With GAD
Phase 2
Phase 2
Clinical Trials (1)
NCT05481905ENACT: A Study of ENX-101 as Adjunctive Treatment in Patients With Focal Seizures
Phase 2
Clinical Trials (1)
NCT07193563A Study to Evaluate the Efficacy and Safety of ENX-102 in Participants With Social Anxiety Disorder
Phase 2

Open Jobs (0)

No open positions listed yet. Check their careers page directly.

Interview Prep Quick Facts
Founded: 2019
Portfolio: 7 clinical trials
Top TAs: Neurology
Publications: 9 in PubMed
Therapeutic Area Focus
Neurology
4 pipeline
Marketed
Pipeline